Literature DB >> 12173406

Clinical benefits of pegylated proteins in oncology.

J Crawford.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12173406     DOI: 10.1016/s0305-7372(02)80001-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  Ultrasound for the treatment of acute kidney injury and other inflammatory conditions: a promising path toward noninvasive neuroimmune regulation.

Authors:  Jieru Cai; William T Nash; Mark D Okusa
Journal:  Am J Physiol Renal Physiol       Date:  2020-06-08

2.  Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia.

Authors:  Feng-Peng Wu; Jun Wang; Hui Wang; Na Li; Yin Guo; Yun-Jie Cheng; Qing Liu; Xiang-Ran Yang
Journal:  Exp Ther Med       Date:  2014-12-30       Impact factor: 2.447

Review 3.  Onto better TRAILs for cancer treatment.

Authors:  D de Miguel; J Lemke; A Anel; H Walczak; L Martinez-Lostao
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.